286 related articles for article (PubMed ID: 26101828)
21. Neuroprotective Effects of Thymol, a Dietary Monoterpene Against Dopaminergic Neurodegeneration in Rotenone-Induced Rat Model of Parkinson's Disease.
Javed H; Azimullah S; Meeran MFN; Ansari SA; Ojha S
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934738
[TBL] [Abstract][Full Text] [Related]
22. Protective Effect of Oral Hesperetin Against Unilateral Striatal 6-Hydroxydopamine Damage in the Rat.
Kiasalari Z; Khalili M; Baluchnejadmojarad T; Roghani M
Neurochem Res; 2016 May; 41(5):1065-72. PubMed ID: 26700436
[TBL] [Abstract][Full Text] [Related]
23. Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences.
Ahmad M; Saleem S; Ahmad AS; Yousuf S; Ansari MA; Khan MB; Ishrat T; Chaturvedi RK; Agrawal AK; Islam F
J Neurochem; 2005 Apr; 93(1):94-104. PubMed ID: 15773909
[TBL] [Abstract][Full Text] [Related]
24. Neuroprotective effects of madecassoside in early stage of Parkinson's disease induced by MPTP in rats.
Xu CL; Qu R; Zhang J; Li LF; Ma SP
Fitoterapia; 2013 Oct; 90():112-8. PubMed ID: 23876367
[TBL] [Abstract][Full Text] [Related]
25. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
[TBL] [Abstract][Full Text] [Related]
26. Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
Aponso PM; Faull RL; Connor B
Neuroscience; 2008 Feb; 151(4):1142-53. PubMed ID: 18201835
[TBL] [Abstract][Full Text] [Related]
27. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies.
Ahmad M; Yousuf S; Khan MB; Hoda MN; Ahmad AS; Ansari MA; Ishrat T; Agrawal AK; Islam F
Pharmacol Biochem Behav; 2006 Jan; 83(1):150-60. PubMed ID: 16500697
[TBL] [Abstract][Full Text] [Related]
28. Tormentic acid confers protection against oxidative stress injury in rats with Parkinson's disease by targeting the Wnt/β-catenin signaling pathway.
Yue Y; Qiao B; Jiang X
Cell Mol Biol (Noisy-le-grand); 2020 Apr; 66(1):32-36. PubMed ID: 32359380
[TBL] [Abstract][Full Text] [Related]
29. Acupuncture inhibits oxidative stress and rotational behavior in 6-hydroxydopamine lesioned rat.
Yu YP; Ju WP; Li ZG; Wang DZ; Wang YC; Xie AM
Brain Res; 2010 Jun; 1336():58-65. PubMed ID: 20399757
[TBL] [Abstract][Full Text] [Related]
30. Cordycepin protects PC12 cells against 6-hydroxydopamine induced neurotoxicity via its antioxidant properties.
Olatunji OJ; Feng Y; Olatunji OO; Tang J; Ouyang Z; Su Z
Biomed Pharmacother; 2016 Jul; 81():7-14. PubMed ID: 27261571
[TBL] [Abstract][Full Text] [Related]
31. AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in vitro and in vivo.
Saal KA; Koch JC; Tatenhorst L; Szegő EM; Ribas VT; Michel U; Bähr M; Tönges L; Lingor P
Neurobiol Dis; 2015 Jan; 73():150-62. PubMed ID: 25283984
[TBL] [Abstract][Full Text] [Related]
32. Neuroprotective and neurotrophic effect of apomorphine in the striatal 6-OHDA-lesion rat model of Parkinson's disease.
Yuan H; Sarre S; Ebinger G; Michotte Y
Brain Res; 2004 Nov; 1026(1):95-107. PubMed ID: 15476701
[TBL] [Abstract][Full Text] [Related]
33. Effects of the hook of Uncaria rhynchophylla on neurotoxicity in the 6-hydroxydopamine model of Parkinson's disease.
Shim JS; Kim HG; Ju MS; Choi JG; Jeong SY; Oh MS
J Ethnopharmacol; 2009 Nov; 126(2):361-5. PubMed ID: 19703534
[TBL] [Abstract][Full Text] [Related]
34. Effect of preconditioned hyperbaric oxygen and ozone on ischemia-reperfusion induced tourniquet in skeletal bone of rats.
Koca K; Yurttas Y; Bilgic S; Cayci T; Topal T; Durusu M; Kaldirim U; Akgul EO; Ozkan H; Yanmis I; Oguz E; Tunay S; Korkmaz A; Basbozkurt M
J Surg Res; 2010 Nov; 164(1):e83-9. PubMed ID: 20850777
[TBL] [Abstract][Full Text] [Related]
35. Puerarin protects dopaminergic neurons against 6-hydroxydopamine neurotoxicity via inhibiting apoptosis and upregulating glial cell line-derived neurotrophic factor in a rat model of Parkinson's disease.
Zhu G; Wang X; Chen Y; Yang S; Cheng H; Wang N; Li Q
Planta Med; 2010 Nov; 76(16):1820-6. PubMed ID: 20509103
[TBL] [Abstract][Full Text] [Related]
36. An intermittent, controlled-rate, slow progressive degeneration model of Parkinson's disease: antiparkinson effects of Sinemet and protective effects of methylphenidate.
Fleming SM; Delville Y; Schallert T
Behav Brain Res; 2005 Jan; 156(2):201-13. PubMed ID: 15582106
[TBL] [Abstract][Full Text] [Related]
37. The neuroprotective potential of sinapic acid in the 6-hydroxydopamine-induced hemi-parkinsonian rat.
Zare K; Eidi A; Roghani M; Rohani AH
Metab Brain Dis; 2015 Feb; 30(1):205-13. PubMed ID: 25123753
[TBL] [Abstract][Full Text] [Related]
38. PEGylated rhFGF-2 conveys long-term neuroprotection and improves neuronal function in a rat model of Parkinson's disease.
Zhu G; Chen G; Shi L; Feng J; Wang Y; Ye C; Feng W; Niu J; Huang Z
Mol Neurobiol; 2015 Feb; 51(1):32-42. PubMed ID: 24930088
[TBL] [Abstract][Full Text] [Related]
39. Neuroprotective effect of IDPU (1-(7-imino-3-propyl-2,3-dihydrothiazolo [4,5-d]pyrimidin-6(7H)-yl)urea) in 6-OHDA induced rodent model of hemiparkinson's disease.
Kumari N; Agrawal S; Kumari R; Sharma D; Luthra PM
Neurosci Lett; 2018 May; 675():74-82. PubMed ID: 29567422
[TBL] [Abstract][Full Text] [Related]
40. Neuroprotective effect of metformin in MPTP-induced Parkinson's disease in mice.
Patil SP; Jain PD; Ghumatkar PJ; Tambe R; Sathaye S
Neuroscience; 2014 Sep; 277():747-54. PubMed ID: 25108167
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
